Douros, A., Dell’Aniello, S., Yu, O.H.Y., et al. (2018) Sulfonylureas as Second Line Drugs in Type 2 Diabetes and the Risk of Cardiovascular and Hypoglycaemic Events: Population Based Cohort Study. BMJ, 362, k2693.
https://doi.org/10.1136/bmj.k2693

has been cited by the following article:

• TITLE: Antidiabetic Prescriptions at the University Hospital Center of Libreville (Gabon) Facing the Concept of Therapeutic Inertia: An Andragogical Perspective

  AUTHORS: Marie-Pierrette Ntyonga-Pono, Marie Félix Gorra, Emeline Mbina-Guidat, Natacha Bililhi-Boubeya, Peggy Bilogue, Ludvine Bifoume-Ndong, Eric Augustin Baye

  KEYWORDS: Anti-Diabetic Prescriptions, Libreville (Gabon), Therapeutic Inertia, Andragogy

  JOURNAL NAME: Journal of Diabetes Mellitus, Vol.8 No.4, November 7, 2018

  ABSTRACT: Context: Diabetes mellitus is experiencing an alarming progression throughout the world, but more and more drugs are available with the use not always adapted. The aim of this work is to analyze the anti-diabetic prescriptions at the university hospital center of Libreville (Gabon) and confront them with the concept of therapeutic inertia. Patients and Methods: In diabetics coming for their periodic control, we transcripted for 2 months, beyond their characteristics, their glycated hemoglobin rate and the treatment followed. Results: 200 patients have consulted and among them, 160 (80%) had done their A1c analysis. 46% had an A1c ≤ 7% and 54% above with sometimes an unsuitable treatment evoking therapeutic inertia, the factors of which we discuss. Conclusion: Therapeutic inertia is a multifactorial problem, one of the components of which may be the resistance to change of the adult learners who are the practitioners.